Example: Heart Attack

Search clinical trials for: Glyburide

Total 127 results

NCT04239586

Enrolling by invitation

Switching From Insulin to Sulfonylurea in Diabetes Associated With Variants in MODY Genes

Conditions: Maturity-Onset Diabetes of the Young, Type 3; Maturity Onset Diabetes of the Young, Type 1; Childhood Diabetes Mellitus; Insulin-dependent Diabetes Mellitus
NCT04231617

Recruiting

The Hemodynamic Effects of CGRP After Glibenclamide Administration in Healthy Volunteers

Conditions: Hemodynamics of Cranial Arteries; Headache; Cerebral Blood Flow
NCT03954041

Recruiting

A Study to Evaluate the Efficacy and Safety of BIIB093 in Participants With Brain Contusion

Conditions: Brain Contusion
NCT03886922

Completed

The Hemodynamics Effect of Levcromakalim After Glibenclamide Administration Assessed by High Resolution Magnetic Resonance Angiography (MRA) Technique in a Randomized Double-blind Cross-over Placebo-controlled Study With Healthy Volunteers

Conditions: Hemodynamics of Cranial Arteries; Headache; Cerebral Blood Flow
NCT03856970

Completed

Study to Evaluate the Effect of IW-3718 on the Pharmacokinetics of Oral Contraceptive, Levothyroxine, Glyburide, and Digoxin in Healthy Adult Volunteers

Conditions: Healthy Volunteers
NCT03855306

Completed

A Bioequivalence Study of Glibenclamide From Glibesyn 5 mg Tablets (Medochemie LTD Cyprus) and Daonil 5 mg Tablets (Sanofi-Aventis Cyprus Ltd. )

Conditions: Healthy
NCT03775902

Completed

Regulation of KATP Channels and Na+/K+ ATPase in Relation to Fatigue Development

Conditions: Type 2 Diabetes Mellitus
NCT03741530

Recruiting

Glibenclamide Advantage in Treating Edema After Intracerebral Hemorrhage

Conditions: Intracerebral Hemorrhage
NCT03569540

Unknown status

Glibenclamide in Aneurysmatic Subarachnoid Hemorrhage

Conditions: Subarachnoid Hemorrhage, Aneurysmal
NCT03527537

Not yet recruiting

Threshold for Initiation of Medical Treatment for Women With Gestational Diabetes

Conditions: Gestational Diabetes
NCT03492580

Completed

A Study for Comparison of Canagliflozin Versus Alternative Antihyperglycemic Treatments on Risk of Heart Failure Hospitalization and Amputation for Participants With Type 2 Diabetes Mellitus and the Subpopulation With Established Cardiovascular Disease

Conditions: Diabetes Mellitus, Type 2; Cardiovascular Diseases
NCT03284463

Recruiting

Safety and Efficacy of Glibenclamide Combined With Rt-PA in Acute Cerebral Embolism

Conditions: Acute Stroke
NCT03089333

Completed

Effects of SGLT2 Inhibitor on Hemodynamic Parameters in Resistant Hypertensive Subjects

Conditions: Hypertension; Diabetes Mellitus, Type 2; Blood Pressure; Obesity; Cardiac Hypertrophy; Microalbuminuria; Vascular Stiffness
NCT03078725

Withdrawn

Failure Rate of GLyburide And Metformin Among Gestational Diabetics

Conditions: Gestational Diabetes Mellitus, Class A2
NCT03029702

Recruiting

Metabolic Analysis for Treatment Choice in Gestational Diabetes Mellitus

Conditions: Gestational Diabetes; Diabetes, Gestational; Pregnancy in Diabetes
NCT02919345

Completed

Assessment of Dapagliflozin Effect on Diabetic Endothelial Dysfunction of Brachial Artery

Conditions: Diabetes Mellitus, Type 2; Coronary Artery Disease; Carotid Artery Diseases
NCT02864953

Recruiting

Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction

Conditions: Brain Edema; Stroke, Acute
NCT02830048

Completed

Low dosE GlibENclamide in Diabetes Part A

Conditions: Diabetes Mellitus, Type 2
NCT02815787

Completed

The Drug -Drug Interaction of SP2086 and Glyburide

Conditions: Type 2 Diabetes
NCT02726490

Terminated

Glyburide vs Glucovance in the Treatment of GDM

Conditions: Gestational Diabetes
NCT02627898

Completed

Effect of Green Tea Extract on Arterial Stiffness in Type 2 Diabetes Mellitus

Conditions: Type 2 Diabetes Mellitus
NCT02624817

Completed

Long-Term Sulfonylurea Response in KCNJ11 Neonatal Diabetes

Conditions: Permanent Neonatal Diabetes Mellitus
NCT02624830

Recruiting

Long-Term Sulfonylurea Response in ABCC8 Neonatal Diabetes (SuResponsSUR)

Conditions: Permanent Neonatal Diabetes Mellitus
NCT02607410

Completed

Sitagliptin (DPP-4 Inhibitor) and NPH Insulin in Patients With T2D

Conditions: Type 2 Diabetes Mellitus
NCT02524379

Recruiting

Spinal Cord Injury Neuroprotection With Glyburide

Conditions: Acute Spinal Cord Injury
NCT02476760

Completed

Incretin-based Drugs and Acute Pancreatitis

Conditions: Diabetes Mellitus, Type 2
NCT02475499

Completed

Incretin-based Drugs and Pancreatic Cancer

Conditions: Diabetes Mellitus, Type 2
NCT02460874

Recruiting

Glyburide vs Placebo as Prophylaxis Against Cerebral Edema in Patients Receiving Radiosurgery for Brain Metastases (RAD 1502/UAB 1593)

Conditions: Cerebral Edema; Brain Metastases
NCT02456428

Completed

Incretin-based Drugs and the Risk of Heart Failure

Conditions: Type 2 Diabetes Mellitus
NCT02406950

Unknown status

Sitagliptin and Endothelial Dysfunction

Conditions: Healthy
NCT02375828

Completed

Glibentek in Patients With Neonatal Diabetes Secondary to Mutations in K+-ATP Channels

Conditions: Neonatal Diabetes Secondary to Mutation in the Potassium Channel
NCT02318693

Completed

Efficacy of Sitagliptin and Glibenclamide on the Glucose Variability in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431-355)

Conditions: Type 2 Diabetes Mellitus
NCT02297126

Active, not recruiting

A Prospective Trial to Assess Cost and Clinical Outcomes of a Clinical Pharmacogenomic Program

Conditions: Adverse Drug Reaction
NCT02255006

Unknown status

Effect of Acupuncture to Endothelial Dysfunction Induced by Ischemia-reperfusion Injury

Conditions: Healthy
NCT02201602

Completed

Sulphonylurea Receptor Mutation and Responsiveness to Gliclazide - a Pilot Proof of Concept, Randomised Cross-over Study

Conditions: Diabetes
NCT02183428

Completed

Bioavailability of BI 1356 and Glyburide in Healthy Male and Female Volunteers

Conditions: Healthy
NCT02145611

Completed

Vildagliptin vs. Glibenclamide in Endothelial Function in Type 2 Diabetes and Hypertension

Conditions: Type 2 Diabetes Mellitus; Hypertension; Endothelial Dysfunction
NCT02128022

Completed

Cardioprotective Effects of GLP-1 and Their Mechanisms

Conditions: Angina Pectoris
NCT02091336

Unknown status

Oral Antidiabetic Agents in Pregnancy

Conditions: Gestational Diabetes
NCT02080377

Completed

A Feasibility Study Looking at the Use of Glibenclamide and metfoRmin Versus stAndard Care in gEstational diabeteS

Conditions: Pregnancy; Gestational Diabetes
NCT01998113

Completed

Glyburide and Metformin for the Treatment of Gestational Diabetes Mellitus. Systematic Review

Conditions: Gestational Diabetes Mellitus
NCT01947699

Withdrawn

Glycemic Profile in Women With Gestational Diabetes Treated With Glyburide

Conditions: Gestational Diabetes
NCT01944618

Terminated

forREAL: FORXIGA PRESCRIPTION EVENT MONITORING PROGRAM (PEMP)

Conditions: Type 2 Diabetes
NCT01940302

Completed

Dietary Supplement of LEHEL for the Patients With Type 2 Diabetes

Conditions: Type 2 Diabetes
NCT01934816

Terminated

Incretin and KATP Channels

Conditions: Healthy Subjects
NCT01867502

Unknown status

Effects of Vildagliptin Versus Glibenclamide on Glycemia After Exercise in Patients With Type 2 Diabetes

Conditions: Diabetes Mellitus, Type 2; Hypoglycemic Agents; Diabetic Blood Glucose Monitoring; Exercise
NCT01822548

Completed

Effect of Vildagliptin vs. Glibenclamide on Circulating Endothelial Progenitor Cell Number Type 2 Diabetes

Conditions: Type 2 Diabetes
NCT01798706

Completed

Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients

Conditions: Type 2 Diabetes
NCT01794182

Unknown status

Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals

Conditions: Ischemic Stroke; Malignant Edema
NCT01733108

Completed

A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics, Pharmacodynamics, and Safety of Glyburide in Healthy Volunteers

Conditions: Healthy

Search clinical trials for: Glyburide

Recent CRA jobs

CRA Line Manager - Home Based - California, Arizona or Nevada

Clinical Research Associate II, Greece

Assoc Clin Sys Support Spec

Associate Scientist - HPLC

CDM Programmer II - CDP (SAS)

Country Approval Spec - Netherlands

Sr Data Analyst

Clinical Trial Assistant - Verona or Milan - Client-dedicated

Contract Administrator II (28 hours per week)

Senior Scientist - HPLC UPLC KF and cGMP